Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension (Q36798684)
Jump to navigation
Jump to search
scientific article published on 7 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension |
scientific article published on 7 April 2015 |
Statements
1 reference
Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension (English)
1 reference
William T Cefalu
1 reference
Lawrence A Leiter
1 reference
Tjerk W A de Bruin
1 reference
Ingrid Gause-Nilsson
1 reference
Jennifer Sugg
1 reference
Shamik J Parikh
1 reference
1 reference
1 reference
Identifiers
1 reference